|
| Study of Chinese medicine regularity on asthma based on the data of literature of Ming and Qing dynasty |
| Hits 1679 Download times 1680 Received:March 20, 2015 |
| View Full Text View/Add Comment Download reader |
| DOI
10.11656/j.issn.1672-1519.2015.07.08 |
| Key Words
asthma;Chinese medicine regularity;literature mining of Ming and Qing dynasty |
| Author Name | Affiliation | | DI Guan-lin | Respiratory Department, The First Affiliated Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin 300193, China | | LIU Gui-ying | Respiratory Department, The First Affiliated Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin 300193, China | | YIN Xin-zhong | Respiratory Department, The First Affiliated Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin 300193, China | | ZHU Zhen-gang | Respiratory Department, The First Affiliated Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin 300193, China |
|
| Abstract
|
| [Objective] To explore the Chinese medicine for asthma's regularity and provide the prescription of clinical medicine for asthma. [Methods] Through arranging and researching the ancient literature of Ming and Qing dynasty, we classified the drugs in the literature of asthma and used SPSS to describe statistics. [Results] The most frequently used Chinese medicine for the treatment of asthma were Glycyrrhizae Radix et Rhizoma(6.89%), Pinellia ternate(5.15%), Amygdalus Communis(4.48%), Pericarpium Citri Reticulatae (3.32%), Herba Ephedrae Sinice(2.89%), Poria Cocos Wolf (2.89%), Panax ginseng C.A.Mey (2.31%), Platycodon grandiflorus (2.26%). According to frequency of traditional Chinese medicine, Huatan zhike pingchuan drugs (27.65%) were most frequently used, followed by Buxu drugs(19.65%) and Jiebiao drugs(12.57%). [Conclusion] The Chinese medicine treated for asthma has its own laws and characteristics. Some drugs are different from drugs used now. But phlegm and retained fluid is still the core pathogenesis in all ages. |
|
|
|
|
|
|
|
